��������

Josefin Bartholdson Scott's work experience is as follows:

- Senior Scientist at Sanofi (January 2022 - present)

- Senior Research Scientist II at Kymab Ltd (July 2021 - present)

- Research Associate at University of Cambridge (April 2017 - July 2021)

- Developed a high-throughput, high-content phenotyping platform for studying antimicrobial resistance and screening therapeutic antibodies against drug-resistant bacteria.

- Involved in glycoconjugate vaccine development, including purification of protein and carbohydrate antigens and chemical conjugation.

- Managed translational projects on the microbiota, antimicrobial resistance, and host responses during infection.

- Postdoctoral Fellow at Wellcome Trust Sanger Institute (June 2009 - March 2017)

- Screened and validated cell surface protein-protein interactions between Plasmodium falciparum merozoites and human erythrocytes.

- Identified and characterized an essential host-pathogen interaction and developed screening methods using flow cytometry and recombinant proteins.

- Optimized host receptor identification using CRISPR/Cas9 and performed protein purification and surface plasmon resonance.

- PhD student at University of Edinburgh (October 2005 - June 2009)

Josefin Bartholdson Scott completed their education in a chronological order. From 1998 to 2001, they attended Malmo Borgarskola, where they pursued an International Baccalaureate degree. Following that, they enrolled at The University of Edinburgh from 2001 to 2004 and obtained a BSc Honours degree in Microbiology and Infection. Finally, they continued their education at The University of Edinburgh from 2005 to 2009, earning a Doctor of Philosophy (PhD) degree in Biochemistry.